These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Frequency and prognostic value of chromosome abnormalities in multiple myeloma]. Kurahashi S, Sawamoto A, Sugimoto T, Narimatsu H, Iwasaki T, Adachi T, Suzuki H, Hayakawa F, Sugiura I. Rinsho Ketsueki; 2007 Nov; 48(11):1455-61. PubMed ID: 18080502 [Abstract] [Full Text] [Related]
24. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients. An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z, Hao M, Feng X, Jin F, Zou D, Qi J, Zhao Y, Tai YT, Wang J, Qiu L. Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928 [Abstract] [Full Text] [Related]
25. Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation. Chang H, Yeung J, Xu W, Ning Y, Patterson B. Br J Haematol; 2006 Sep; 134(6):613-5. PubMed ID: 16889615 [Abstract] [Full Text] [Related]
26. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation. Johnson MR, Del Carpio-Jayo D, Lin P, Giralt S, Anderlini P, Champlin RE, Khouri IF, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE. Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517 [Abstract] [Full Text] [Related]
30. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis. Koren-Michowitz M, Hardan I, Berghoff J, Yshoev G, Amariglio N, Rechavi G, Nagler A, Trakhtenbrot L. Cancer Lett; 2007 Oct 08; 255(2):307-14. PubMed ID: 17590504 [Abstract] [Full Text] [Related]
32. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome. Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L, Lombardi L, Grieco V, Bianchino G, D'Auria F, Statuto T, Mazzoccoli C, De Luca L, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Omede' P, Tassone P, Boccadoro M, Palumbo A, Neri A, Musto P. Clin Cancer Res; 2013 Jun 15; 19(12):3247-58. PubMed ID: 23599371 [Abstract] [Full Text] [Related]
33. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. García-Sanz R, Orfão A, González M, Tabernero MD, Bladé J, Moro MJ, Fernández-Calvo J, Sanz MA, Pérez-Simón JA, Rasillo A, Miguel JF. Blood; 1999 Feb 01; 93(3):1032-7. PubMed ID: 9920853 [Abstract] [Full Text] [Related]
34. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T, Kalla J, Ott G, Müller-Hermelink HK, Barth TF, Möller P, Lichter P, Döhner H, Stilgenbauer S. Haematologica; 2008 May 01; 93(5):680-7. PubMed ID: 18367489 [Abstract] [Full Text] [Related]